miR-182-5p improves the viability, mitosis, migration, and invasion ability of human gastric cancer cells by down-regulating RAB27A
We investigated the effect of miR-182-5p on the viability, proliferation, invasion, and migration ability of human gastric cells by regulating the expression of RAB27A. Real-time PCR assay was used to detect the expression of miR-182-5 and RAB27A in human gastric carcinoma tissues, para-carcinoma ti...
Saved in:
Published in | Bioscience reports Vol. 37; no. 3 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Portland Press Ltd
30.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We investigated the effect of miR-182-5p on the viability, proliferation, invasion, and migration ability of human gastric cells by regulating the expression of RAB27A. Real-time PCR assay was used to detect the expression of miR-182-5 and RAB27A in human gastric carcinoma tissues, para-carcinoma tissues, and different cell lines. Western blotting was also used to determine the RAB27A expression in both tissues and cell lines. We chose the HGC-27 cell line as experiment subject as it demonstrated the highest miR-182-5p level. HGC-27 cells were transfected with different vectors and the cell viability, mitosis, invasion, and migration ability were measured through MTT assay, flow cytometry (FCM) analysis, Transwell assay, and wound healing assay. In comparison with the normal tissues, miR-182-5p is expressed at a higher level in gastric cancer (GC) tissues, while RAB27A is expressed at a lower level in cancerous tissues. The down-regulation of miR-182-5p and up-regulation of RAB27A can significantly decrease the viability, migration, invasion, and mitosis of HGC-27 cells. The target relationship between miR-182-5p and RAb27A was confirmed through a dual-luciferase reporter gene assay and Western blot assay. miR-182-5p enhances the viability, mitosis, migration, and invasion of human GC cells by down-regulating RAB27A. |
---|---|
AbstractList | We investigated the effect of miR-182-5p on the viability, proliferation, invasion, and migration ability of human gastric cells by regulating the expression of RAB27A. Real-time PCR assay was used to detect the expression of miR-182-5 and RAB27A in human gastric carcinoma tissues, para-carcinoma tissues, and different cell lines. Western blotting was also used to determine the RAB27A expression in both tissues and cell lines. We chose the HGC-27 cell line as experiment subject as it demonstrated the highest miR-182-5p level. HGC-27 cells were transfected with different vectors and the cell viability, mitosis, invasion, and migration ability were measured through MTT assay, flow cytometry (FCM) analysis, Transwell assay, and wound healing assay. In comparison with the normal tissues, miR-182-5p is expressed at a higher level in gastric cancer (GC) tissues, while RAB27A is expressed at a lower level in cancerous tissues. The down-regulation of miR-182-5p and up-regulation of RAB27A can significantly decrease the viability, migration, invasion, and mitosis of HGC-27 cells. The target relationship between miR-182-5p and RAb27A was confirmed through a dual-luciferase reporter gene assay and Western blot assay. miR-182-5p enhances the viability, mitosis, migration, and invasion of human GC cells by down-regulating RAB27A. We investigated the effect of miR-182-5p on the viability, proliferation, invasion, and migration ability of human gastric cells by regulating the expression of RAB27A. Real-time PCR assay was used to detect the expression of miR-182-5 and RAB27A in human gastric carcinoma tissues, para-carcinoma tissues, and different cell lines. Western blotting was also used to determine the RAB27A expression in both tissues and cell lines. We chose the HGC-27 cell line as experiment subject as it demonstrated the highest miR-182-5p level. HGC-27 cells were transfected with different vectors and the cell viability, mitosis, invasion, and migration ability were measured through MTT assay, flow cytometry (FCM) analysis, Transwell assay, and wound healing assay. In comparison with the normal tissues, miR-182-5p is expressed at a higher level in gastric cancer (GC) tissues, while RAB27A is expressed at a lower level in cancerous tissues. The down-regulation of miR-182-5p and up-regulation of RAB27A can significantly decrease the viability, migration, invasion, and mitosis of HGC-27 cells. The target relationship between miR-182-5p and RAb27A was confirmed through a dual-luciferase reporter gene assay and Western blot assay. miR-182-5p enhances the viability, mitosis, migration, and invasion of human GC cells by down-regulating RAB27A.We investigated the effect of miR-182-5p on the viability, proliferation, invasion, and migration ability of human gastric cells by regulating the expression of RAB27A. Real-time PCR assay was used to detect the expression of miR-182-5 and RAB27A in human gastric carcinoma tissues, para-carcinoma tissues, and different cell lines. Western blotting was also used to determine the RAB27A expression in both tissues and cell lines. We chose the HGC-27 cell line as experiment subject as it demonstrated the highest miR-182-5p level. HGC-27 cells were transfected with different vectors and the cell viability, mitosis, invasion, and migration ability were measured through MTT assay, flow cytometry (FCM) analysis, Transwell assay, and wound healing assay. In comparison with the normal tissues, miR-182-5p is expressed at a higher level in gastric cancer (GC) tissues, while RAB27A is expressed at a lower level in cancerous tissues. The down-regulation of miR-182-5p and up-regulation of RAB27A can significantly decrease the viability, migration, invasion, and mitosis of HGC-27 cells. The target relationship between miR-182-5p and RAb27A was confirmed through a dual-luciferase reporter gene assay and Western blot assay. miR-182-5p enhances the viability, mitosis, migration, and invasion of human GC cells by down-regulating RAB27A. |
Author | Yu, Shengqiang Bi, Liyan Chen, Shudong Li, Yongwei Xu, Sen Shan, Zhengfei Li, Yuling |
Author_xml | – sequence: 1 givenname: Yuling surname: Li fullname: Li, Yuling organization: Department of Pathophysiology, Binzhou Medical University, Yantai 264003, Shandong, China – sequence: 2 givenname: Shudong surname: Chen fullname: Chen, Shudong organization: Department of Gastrointestinal Surgery Ward II, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong, China – sequence: 3 givenname: Zhengfei surname: Shan fullname: Shan, Zhengfei organization: Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong, China – sequence: 4 givenname: Liyan surname: Bi fullname: Bi, Liyan organization: Department of Transformative Otology and Neuroscience Center, Binzhou Medical University, Yantai 264003, Shandong, China – sequence: 5 givenname: Shengqiang surname: Yu fullname: Yu, Shengqiang organization: Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong, China – sequence: 6 givenname: Yongwei surname: Li fullname: Li, Yongwei organization: Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong, China – sequence: 7 givenname: Sen surname: Xu fullname: Xu, Sen organization: Department of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai 264003, Shandong, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28546229$$D View this record in MEDLINE/PubMed |
BookMark | eNptkc1v1DAQxS1URLeFE3fkI1Ib8FcS54K0rQpUqlRpgbPl-CNrlNiL7SzaM_94vXRblYrTeDRvfk9-cwKOfPAGgLcYfcCIkY8X31YE4RZh2rwAC1y3tGIdrY_AAmHGKs4aegxOUvqJECoD9gocE16zhpBuAf5MblVhTqp6A920iWFrEsxrA7dO9m50eXcOJ5dDcmn_GKLMLvhzKL2Gzm9lKh08KGGwcD1P0sNBphydgkp6ZSJUZhwT7HdQh9--imaYx4LxA1wtL0i7fA1eWjkm8-ZQT8GPz1ffL79WN7dfri-XN5WiHOeKUN1ZZhFHmjWsMS3SWHHeGEJY11piLe4Z0Ugpqa0sCbBOEtlrVBtONEH0FHy6527mfjJaGZ-jHMUmuknGnQjSiX8n3q3FELaiYZQhzgrg_QEQw6_ZpCwml_afk96EOQncIYrrrqZNkb576vVo8pB8EeB7gYohpWisUC7_DbdYu1FgJPbXFU-uW3bOnu08YP-nvgMsPaXE |
CitedBy_id | crossref_primary_10_1080_15384101_2022_2060640 crossref_primary_10_3390_cells9030639 crossref_primary_10_1158_1541_7786_MCR_19_0725 crossref_primary_10_1080_1061186X_2024_2309563 crossref_primary_10_1016_j_lfs_2020_117741 crossref_primary_10_1016_j_jns_2020_116689 crossref_primary_10_1177_0963689720943613 crossref_primary_10_1002_jcp_28995 crossref_primary_10_1097_ICL_0000000000000573 crossref_primary_10_1186_s13048_019_0580_7 crossref_primary_10_1007_s12257_021_0019_z crossref_primary_10_1016_j_bbrep_2021_101079 crossref_primary_10_1016_j_bcp_2021_114409 crossref_primary_10_1016_j_biopha_2017_08_144 crossref_primary_10_1007_s00432_019_02940_0 crossref_primary_10_1186_s12935_023_02972_0 crossref_primary_10_1038_s41598_020_64781_z crossref_primary_10_1093_abbs_gmab015 crossref_primary_10_1080_21541248_2017_1397833 crossref_primary_10_1007_s12253_019_00647_8 crossref_primary_10_1155_2021_7074343 crossref_primary_10_1186_s12943_020_1132_x crossref_primary_10_1007_s12035_019_01717_3 crossref_primary_10_1177_1533033820915958 crossref_primary_10_5604_01_3001_0012_7902 crossref_primary_10_1002_jcb_30473 crossref_primary_10_1155_2020_2862701 crossref_primary_10_3349_ymj_2019_60_2_148 crossref_primary_10_1016_j_biopha_2019_108814 |
Cites_doi | 10.1038/cgt.2015.44 10.1371/journal.pone.0055502 10.1007/s13277-013-0756-5 10.1111/j.1440-1746.2008.05753.x 10.1093/jnci/djq153 10.1016/j.semcdb.2010.12.005 10.1053/srao.30814 10.1016/S0140-6736(03)13975-X 10.1073/pnas.0808263106 10.1016/j.acthis.2016.02.001 10.1371/journal.pone.0051056 10.1186/1476-4598-13-109 10.1073/pnas.0601617103 10.3322/caac.21208 10.3748/wjg.v22.i6.2060 10.1002/jso.23262 10.1007/s10719-012-9387-0 10.1007/s12032-014-0372-2 10.1038/onc.2013.65 10.1111/tra.12083 10.3322/caac.21262 10.3748/wjg.v18.i15.1806 10.1111/apm.12261 10.1002/cncr.24743 10.3892/ol.2013.1428 10.1111/jcmm.12706 10.3748/wjg.v20.i7.1635 10.1186/1479-5876-12-109 10.1016/j.cell.2009.01.002 10.1016/j.bbrc.2014.06.073 10.1371/journal.pone.0121175 10.1007/s11033-014-3045-5 10.1371/journal.pone.0089782 10.1097/MOG.0b013e32833efd9b 10.1158/1541-7786.MCR-07-0162 10.1126/science.1258040 10.1158/0008-5472.CAN-12-0925 |
ContentType | Journal Article |
Copyright | 2017 The Author(s). 2017 The Author(s). 2017 |
Copyright_xml | – notice: 2017 The Author(s). – notice: 2017 The Author(s). 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1042/BSR20170136 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1573-4935 |
ExternalDocumentID | PMC6434084 28546229 10_1042_BSR20170136 |
Genre | Journal Article |
GroupedDBID | --- .86 0R~ 23N 4.4 5GY 5RE 5VS 6J9 78A AAYXX ABJNI ACGFS ACIWK ACPRK ADBBV ADIMF ADRAZ AEGXH AENEX AFBBN AFRAH AHBYD ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR BGNMA CITATION CS3 DIK DL5 DU5 E3Z EBD EBS EJD EMOBN EPAXT F5P FRP GX1 H13 HYE HZ~ I09 IZQ KDC KQ8 LAK M48 M4Y MV1 NU0 O9- OK1 OVD QOK QOS R4E RHI RNS RPM RPO RPX RRX SBL SDH SDM SOJ SV3 TR2 TSK U2A VC2 ~EX AABGO CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c381t-23d9f4f080d4646e70d1c886e22497f2ff1b42d0ccadfa93549a2abd05e82d203 |
IEDL.DBID | M48 |
ISSN | 0144-8463 1573-4935 |
IngestDate | Thu Aug 21 18:06:56 EDT 2025 Thu Jul 10 19:03:05 EDT 2025 Thu Apr 03 07:05:36 EDT 2025 Thu Apr 24 22:58:23 EDT 2025 Tue Jul 01 02:33:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | gastric cancer RAB27A miR-182-5p |
Language | English |
License | 2017 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c381t-23d9f4f080d4646e70d1c886e22497f2ff1b42d0ccadfa93549a2abd05e82d203 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Correction/Retraction-3 The authors contributed equally to this work. |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1042/BSR20170136 |
PMID | 28546229 |
PQID | 1903159536 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6434084 proquest_miscellaneous_1903159536 pubmed_primary_28546229 crossref_citationtrail_10_1042_BSR20170136 crossref_primary_10_1042_BSR20170136 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-06-30 |
PublicationDateYYYYMMDD | 2017-06-30 |
PublicationDate_xml | – month: 06 year: 2017 text: 2017-06-30 day: 30 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Bioscience reports |
PublicationTitleAlternate | Biosci Rep |
PublicationYear | 2017 |
Publisher | Portland Press Ltd |
Publisher_xml | – name: Portland Press Ltd |
References | Terry (2021111618464081500_B4) 2002; 12 Xu (2021111618464081500_B28) 2014; 13 Hu (2021111618464081500_B38) 2015; 10 Schirle (2021111618464081500_B22) 2014; 346 Mitra (2021111618464081500_B34) 2011; 22 Dong (2021111618464081500_B20) 2012; 18 Zhang (2021111618464081500_B12) 2015; 22 Segura (2021111618464081500_B31) 2009; 106 Sun (2021111618464081500_B39) 2015; 8 Zhu (2021111618464081500_B36) 2014; 450 Wang (2021111618464081500_B14) 2015; 32 Feng (2021111618464081500_B30) 2012; 29 Xu (2021111618464081500_B7) 2013; 6 Li (2021111618464081500_B29) 2014; 41 Wang (2021111618464081500_B24) 2016; 118 Wu (2021111618464081500_B35) 2013; 34 Li (2021111618464081500_B15) 2014; 122 Siegel (2021111618464081500_B5) 2014; 64 Hirata (2021111618464081500_B26) 2012; 7 Torre (2021111618464081500_B1) 2015; 65 Wang (2021111618464081500_B16) 2008; 6 Dong (2021111618464081500_B13) 2015; 20 Wang (2021111618464081500_B19) 2014; 9 Hirata (2021111618464081500_B27) 2013; 8 Hendrix (2021111618464081500_B18) 2010; 102 Wu (2021111618464081500_B6) 2009; 24 Hohenberger (2021111618464081500_B9) 2003; 362 Gao (2021111618464081500_B10) 2010; 116 Lei (2021111618464081500_B32) 2014; 33 Yang (2021111618464081500_B37) 2014; 12 Fukuda (2021111618464081500_B11) 2013; 14 Guggenheim (2021111618464081500_B2) 2013; 107 Orditura (2021111618464081500_B8) 2014; 20 Bobrie (2021111618464081500_B17) 2012; 72 Xu (2021111618464081500_B25) 2016; 20 Jiang (2021111618464081500_B3) 2010; 26 Grosshans (2021111618464081500_B33) 2006; 103 Bartel (2021111618464081500_B21) 2009; 136 Vidal (2021111618464081500_B23) 2016; 22 |
References_xml | – volume: 22 start-page: 475 year: 2015 ident: 2021111618464081500_B12 article-title: Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma publication-title: Cancer Gene Ther. doi: 10.1038/cgt.2015.44 – volume: 8 start-page: e55502 year: 2013 ident: 2021111618464081500_B27 article-title: MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer publication-title: PLoS ONE doi: 10.1371/journal.pone.0055502 – volume: 34 start-page: 2195 year: 2013 ident: 2021111618464081500_B35 article-title: Effects of Rab27a on proliferation, invasion, and anti-apoptosis in human glioma cell publication-title: Tumour Biol. doi: 10.1007/s13277-013-0756-5 – volume: 24 start-page: 37 year: 2009 ident: 2021111618464081500_B6 article-title: Molecular basis of therapeutic approaches to gastric cancer publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/j.1440-1746.2008.05753.x – volume: 102 start-page: 866 year: 2010 ident: 2021111618464081500_B18 article-title: Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djq153 – volume: 22 start-page: 57 year: 2011 ident: 2021111618464081500_B34 article-title: Rab GTPases implicated in inherited and acquired disorders publication-title: Semin. Cell Dev. Biol. doi: 10.1016/j.semcdb.2010.12.005 – volume: 12 start-page: 111 year: 2002 ident: 2021111618464081500_B4 article-title: The epidemiology of gastric cancer publication-title: Semin. Radiat. Oncol. doi: 10.1053/srao.30814 – volume: 362 start-page: 305 year: 2003 ident: 2021111618464081500_B9 article-title: Gastric cancer publication-title: Lancet doi: 10.1016/S0140-6736(03)13975-X – volume: 106 start-page: 1814 year: 2009 ident: 2021111618464081500_B31 article-title: Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0808263106 – volume: 118 start-page: 323 year: 2016 ident: 2021111618464081500_B24 article-title: MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1 publication-title: Acta. Histochem. doi: 10.1016/j.acthis.2016.02.001 – volume: 7 start-page: e51056 year: 2012 ident: 2021111618464081500_B26 article-title: Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer publication-title: PLoS ONE doi: 10.1371/journal.pone.0051056 – volume: 13 start-page: 109 year: 2014 ident: 2021111618464081500_B28 article-title: Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway publication-title: Mol. Cancer doi: 10.1186/1476-4598-13-109 – volume: 20 start-page: 357 year: 2015 ident: 2021111618464081500_B13 article-title: Decreased expression of Rab27A and Rab27B correlates with metastasis and poor prognosis in colorectal cancer publication-title: Discov. Med. – volume: 103 start-page: 11821 year: 2006 ident: 2021111618464081500_B33 article-title: Rabs and their effectors: achieving specificity in membrane traffic publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0601617103 – volume: 8 start-page: 4755 year: 2015 ident: 2021111618464081500_B39 article-title: miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a publication-title: Int. J. Clin. Exp. Pathol. – volume: 64 start-page: 9 year: 2014 ident: 2021111618464081500_B5 article-title: Cancer statistics, 2014 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21208 – volume: 22 start-page: 2060 year: 2016 ident: 2021111618464081500_B23 article-title: hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v22.i6.2060 – volume: 107 start-page: 230 year: 2013 ident: 2021111618464081500_B2 article-title: Gastric cancer epidemiology and risk factors publication-title: J. Surg. Oncol. doi: 10.1002/jso.23262 – volume: 29 start-page: 503 year: 2012 ident: 2021111618464081500_B30 article-title: MicroRNA-125a inhibits cell growth by targeting glypican-4 publication-title: Glycoconj. J. doi: 10.1007/s10719-012-9387-0 – volume: 32 start-page: 372 year: 2015 ident: 2021111618464081500_B14 article-title: High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival publication-title: Med. Oncol. doi: 10.1007/s12032-014-0372-2 – volume: 33 start-page: 1287 year: 2014 ident: 2021111618464081500_B32 article-title: Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis publication-title: Oncogene doi: 10.1038/onc.2013.65 – volume: 14 start-page: 949 year: 2013 ident: 2021111618464081500_B11 article-title: Rab27 effectors, pleiotropic regulators in secretory pathways publication-title: Traffic doi: 10.1111/tra.12083 – volume: 65 start-page: 87 year: 2015 ident: 2021111618464081500_B1 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21262 – volume: 18 start-page: 1806 year: 2012 ident: 2021111618464081500_B20 article-title: Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v18.i15.1806 – volume: 122 start-page: 1080 year: 2014 ident: 2021111618464081500_B15 article-title: Rab27A regulates exosome secretion from lung adenocarcinoma cells A549: involvement of EPI64 publication-title: APMIS doi: 10.1111/apm.12261 – volume: 116 start-page: 41 year: 2010 ident: 2021111618464081500_B10 article-title: Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer publication-title: Cancer doi: 10.1002/cncr.24743 – volume: 6 start-page: 631 year: 2013 ident: 2021111618464081500_B7 article-title: miRNA: The nemesis of gastric cancer (Review) publication-title: Oncol. Lett. doi: 10.3892/ol.2013.1428 – volume: 20 start-page: 95 year: 2016 ident: 2021111618464081500_B25 article-title: miRNA-532-5p functions as an oncogenic microRNA in human gastric cancer by directly targeting RUNX3 publication-title: J. Cell. Mol. Med. doi: 10.1111/jcmm.12706 – volume: 20 start-page: 1635 year: 2014 ident: 2021111618464081500_B8 article-title: Treatment of gastric cancer publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v20.i7.1635 – volume: 12 start-page: 109 year: 2014 ident: 2021111618464081500_B37 article-title: microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis publication-title: J. Transl. Med. doi: 10.1186/1479-5876-12-109 – volume: 136 start-page: 215 year: 2009 ident: 2021111618464081500_B21 article-title: MicroRNAs: target recognition and regulatory functions publication-title: Cell doi: 10.1016/j.cell.2009.01.002 – volume: 450 start-page: 857 year: 2014 ident: 2021111618464081500_B36 article-title: miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2014.06.073 – volume: 10 start-page: e0121175 year: 2015 ident: 2021111618464081500_B38 article-title: The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression publication-title: PLoS One doi: 10.1371/journal.pone.0121175 – volume: 41 start-page: 1977 year: 2014 ident: 2021111618464081500_B29 article-title: MiR-200a is involved in proliferation and apoptosis in the human endometrial adenocarcinoma cell line HEC-1B by targeting the tumor suppressor PTEN publication-title: Mol. Biol. Rep. doi: 10.1007/s11033-014-3045-5 – volume: 9 start-page: e89782 year: 2014 ident: 2021111618464081500_B19 article-title: Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas publication-title: PLoS ONE doi: 10.1371/journal.pone.0089782 – volume: 26 start-page: 640 year: 2010 ident: 2021111618464081500_B3 article-title: Multidisciplinary management of gastric cancer publication-title: Curr. Opin. Gastroenterol. doi: 10.1097/MOG.0b013e32833efd9b – volume: 6 start-page: 372 year: 2008 ident: 2021111618464081500_B16 article-title: Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-07-0162 – volume: 346 start-page: 608 year: 2014 ident: 2021111618464081500_B22 article-title: Structural basis for microRNA targeting publication-title: Science doi: 10.1126/science.1258040 – volume: 72 start-page: 4920 year: 2012 ident: 2021111618464081500_B17 article-title: Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-0925 |
SSID | ssj0004934 |
Score | 2.3493488 |
Snippet | We investigated the effect of miR-182-5p on the viability, proliferation, invasion, and migration ability of human gastric cells by regulating the expression... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
SubjectTerms | Cell Line, Tumor Cell Movement Cell Survival Down-Regulation Gene Expression Regulation, Neoplastic Humans MicroRNAs - genetics Mitosis Neoplasm Invasiveness - genetics Neoplasm Invasiveness - pathology rab27 GTP-Binding Proteins - genetics Stomach Neoplasms - genetics Stomach Neoplasms - pathology |
Title | miR-182-5p improves the viability, mitosis, migration, and invasion ability of human gastric cancer cells by down-regulating RAB27A |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28546229 https://www.proquest.com/docview/1903159536 https://pubmed.ncbi.nlm.nih.gov/PMC6434084 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwELZgUUUviFIKSylypZ4qTBM_8jggtKAi2qo9bLsSt8hPiARZutlF3XP_eMdxgnYpB26WMkmsGVvz2WN_H0IfdGIikzFG4lhJWKAoRzIhHVGaKpFHQgnTnPL9kVyM-NdLcbmCOjHO1oH1k0s7ryc1mtwc_fk9P4EJfxwqlPTT6c8h9TQwMUtW0RqkpNTP0O98gTY8D-VlkTICbdFe1Hv08nJq-g9vPj42uZCHzjfRRgsg8SBE_BVasdUWehEkJedbaP2sU3B7jf7elkMCyJ6IO1w2mwe2xgD48H0Z2Lnnh_gWZnRd1r5xFQbDIZaVwWV1L_1GGm4t8djhRs8PX0kv9aGx9uNlgv3Of43VHBtYz5NJkLaHfIiHg1OaDrbR6Pzzr7ML0oouEA3Je0ooM7njDoCk4QlPbBqZWGdZYiHX56mjzsWKUxNB5I2T4EueSyqViYTNqKERe4N61biyuwj6waxn9LNZxLk2WgI65DRNFPflYWb66GPn70K3jOReGOOmaCrjnBYLwenDuOqM7wIRx9Nm77vAFeBt7wNZ2fGsLgD5MMBuwtvshEA-fMhfI00ozfsoXQrxg4En4V5-UpXXDRk3IDoeZXzvGf99i176bobThvuoN53M7DuANFN1AGD-y7eDZtD-A4wj9Xk |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=miR-182-5p+improves+the+viability%2C+mitosis%2C+migration%2C+and+invasion+ability+of+human+gastric+cancer+cells+by+down-regulating+RAB27A&rft.jtitle=Bioscience+reports&rft.au=Li%2C+Yuling&rft.au=Chen%2C+Shudong&rft.au=Shan%2C+Zhengfei&rft.au=Bi%2C+Liyan&rft.date=2017-06-30&rft.issn=1573-4935&rft.eissn=1573-4935&rft.volume=37&rft.issue=3&rft_id=info:doi/10.1042%2FBSR20170136&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0144-8463&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0144-8463&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0144-8463&client=summon |